The ramp-up of coronavirus drug and vaccine manufacturing is causing shortages of drugs that hospitals commonly use, according to a study by Premier Inc. “Alongside the emergence of the Omicron variant and ongoing disease spikes, the prioritization of COVID-19 vaccine production is both rational and prudent. However, a highly consolidated supply chain has created unreasonable demand and overreliance on manufacturers who find challenges in expanding production or shifting capacity in a resource-constrained environment,” Premier said in a Dec. 21 blog...